Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 3,121 |
|
|||||
| News | - | ||||||
| Day High | 1.12 | Low High |
|||||
| Day Low | 1.04 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| HCW Biologics Inc | HCWB | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.003 | 0.27% | 1.12 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.10 | 1.04 | 1.12 | 1.12 | 1.117 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 41 | 3,121 | US$ 1.06 | US$ 3,315 | - | 0.91 - 2.32 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 15:00:00 | 30 | US$ 1.13 | USD |
HCW Biologics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 40.29M | 35.97M | - | 2.84M | -24.99M | -0.69 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
HCW Biologics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical HCWB Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.07 | 1.2158 | 1.00 | 1.07 | 8,727 | 0.05 | 4.67% |
| 1 Month | 1.10 | 1.2158 | 1.00 | 1.09 | 11,635 | 0.02 | 1.82% |
| 3 Months | 1.71 | 1.93 | 1.00 | 1.25 | 12,848 | -0.59 | -34.50% |
| 6 Months | 1.22 | 1.93 | 1.00 | 1.34 | 15,201 | -0.10 | -8.20% |
| 1 Year | 2.12 | 2.32 | 0.91 | 1.51 | 13,857 | -1.00 | -47.17% |
| 3 Years | 7.50 | 7.51 | 0.91 | 4.42 | 292,330 | -6.38 | -85.07% |
| 5 Years | 7.50 | 7.51 | 0.91 | 4.42 | 292,330 | -6.38 | -85.07% |
HCW Biologics Description
| HCW Biologics Inc is a biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company believes age-related low-grade chronic inflammation is a significant contributing factor to several chronic diseases and conditions, such as cancer, cardiovascular disease, diabetes, neurodegenerative diseases, and autoimmune diseases. |
